Display options
Share it on

Clin Exp Immunol. 1988 Jul;73(1):63-9.

T lymphocytes of the human colonic mucosa: functional and phenotypic analysis.

Clinical and experimental immunology

C J Smart, L K Trejdosiewicz, S Badr-el-Din, R V Heatley

Affiliations

  1. Department of Medicine, University of Leeds, St James's Hospital, UK.

PMID: 2971488 PMCID: PMC1541457

Abstract

Normal human colonic lymphocyte populations were isolated for both phenotypic analysis by double-label immunofluorescence and assessment for regulatory effects on Ig production by co-culture with responder cells from colonic mucosa and peripheral blood. Mean CD4:CD8 ratios for colonic intraepithelial lymphocytes (IEL) and lamina propria lymphocytes (LPL) were comparable to values obtained from tissue sections. IEL alone did not produce Ig in vitro and were without effect on Ig production when co-cultured with LPL. However, T-enriched LPL had a marked helper effect for T-depleted LPL. Maximal help was for IgA production, increasing with numbers of T-enriched cells. In colonic LPL T-depleted and T-enriched co-cultures, pokeweed mitogen (PWM) had no significant effect. By contrast, in co-cultures of T-enriched and T-depleted peripheral blood mononuclear cells, Ig production was PWM-dependent. In all experiments with colonic mucosal responder cells, IgG production was low. The effects of unfractionated colonic biopsy lymphocytes on T-depleted peripheral blood mononuclear cells were additive for IgM production and synergistic for IgA synthesis, although almost no IgG was produced. Moreover, PWM had helper effects for IgM, but was suppressive for IgA production. These data suggest that colonic mucosal regulatory cells reside in the lamina propria, and predominantly provide help for IgA and IgM synthesis. The data further suggest the existence of a pre-stimulated IgA-specific T helper cell population.

Similar articles

References

  1. J Immunol Methods. 1987 Mar 12;97(2):269-74 - PubMed
  2. Clin Exp Immunol. 1983 Dec;54(3):739-46 - PubMed
  3. Lab Invest. 1974 Mar;30(3):260-6 - PubMed
  4. J Clin Invest. 1977 May;59(5):966-74 - PubMed
  5. Adv Exp Med Biol. 1978;107:53-9 - PubMed
  6. J Exp Med. 1979 Mar 1;149(3):632-43 - PubMed
  7. Gastroenterology. 1979 Sep;77(3):503-10 - PubMed
  8. Dig Dis Sci. 1979 Sep;24(9):705-17 - PubMed
  9. Gut. 1981 Mar;22(3):177-86 - PubMed
  10. Gastroenterology. 1981 Nov;81(5):844-52 - PubMed
  11. Gastroenterology. 1983 Jan;84(1):178-85 - PubMed
  12. J Clin Pathol. 1983 Apr;36(4):379-84 - PubMed
  13. J Immunol. 1983 Jun;130(6):2615-22 - PubMed
  14. Ann N Y Acad Sci. 1983 Jun 30;409:284-91 - PubMed
  15. Ann N Y Acad Sci. 1983 Jun 30;409:498-509 - PubMed
  16. Gastroenterology. 1983 Nov;85(5):1023-35 - PubMed
  17. Adv Exp Med Biol. 1987;216A:465-73 - PubMed
  18. Gut. 1984 Jan;25(1):32-40 - PubMed
  19. Gut. 1984 Jan;25(1):47-51 - PubMed
  20. Clin Exp Immunol. 1984 Apr;56(1):159-66 - PubMed
  21. Gut. 1984 Jun;25(6):649-55 - PubMed
  22. Gastroenterology. 1985 May;88(5 Pt 1):1143-50 - PubMed
  23. Immunology. 1985 Apr;54(4):713-22 - PubMed
  24. Clin Exp Immunol. 1985 May;60(2):437-46 - PubMed
  25. Gastroenterology. 1985 Aug;89(2):321-7 - PubMed
  26. Scand J Gastroenterol Suppl. 1985;114:1-15 - PubMed
  27. Scand J Gastroenterol Suppl. 1985;114:17-38 - PubMed
  28. Dig Dis Sci. 1986 Jun;31(6):593-603 - PubMed
  29. Gastroenterology. 1986 Sep;91(3):746-68 - PubMed
  30. J Clin Immunol. 1987 Jul;7(4):265-76 - PubMed
  31. J Exp Med. 1972 Aug 1;136(2):207-15 - PubMed

Substances

MeSH terms

Publication Types

LinkOut - more resources